| Primary information |
|---|
| sequence ID | Seq_8520 |
| Peptide sequence | TQEKNPLPSKETIEQE |
| CancerPDF_ID | CancerPDF_ID912, CancerPDF_ID12471, |
| PMID | 19795908,26992070 |
| Protein Name | Thymosin beta-4,Thymosin beta-4 |
| UniprotKB Entry Name | TYB4_HUMAN,TYB4_HUMAN |
| Fluid | Plasma,Serum |
| M/Z | 624.3,1869.932 |
| Charge | 3,NA |
| Mass (in Da) | NA,1870.946567 |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | MALDI-TOF/TOF,LC-MS/MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
| Labelled/Label Free | Labelled,Label Free |
| FDR | less than 7%,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID912, CancerPDF_ID12471, |
| p-Value | NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,SEQUEST and Maxquant |
| Length | 16,16 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Melanoma |
| Database | NCBI refseq Protein Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | "31normal, 14patients",8 cancer samples and 4 healthy samples |
| Regulation | NA,"Present in 2 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." |
| Validation | NA,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | 502874
503099
|